Banque de Luxembourg Investments (BLI)’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.6M Hold
49,900
0.41% 65
2025
Q4
$13.8M Sell
49,900
-3,000
-6% -$821K 0.41% 66
2025
Q3
$13.8M Hold
52,900
0.4% 67
2025
Q2
$11.6M Sell
52,900
-3,200
-6% -$684K 0.33% 84
2025
Q1
$12.4M Buy
56,100
+5,000
+10% +$1.38M 0.38% 72
2024
Q4
$16.8M Buy
+51,100
New +$16.1M 0.46% 56

Other funds holding WST

Banque de Luxembourg Investments (BLI)'s WST Position: Q1 2026 in Review

Banque de Luxembourg Investments (BLI) held its West Pharmaceutical (WST) position steady in Q1 2026 at 49,900 shares worth $13.6M. The position accounts for 0.41% of the portfolio, ranked #65.

Banque de Luxembourg Investments (BLI) first reported a position in WST in Q4 2024 and has held it in 6 quarters since. The position peaked at $16.8M in Q4 2024. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Banque de Luxembourg Investments (BLI) held 49,900 shares of West Pharmaceutical worth $13.6M as of Q1 2026.
  • Banque de Luxembourg Investments (BLI) left its West Pharmaceutical share count unchanged in Q1 2026.
  • West Pharmaceutical made up 0.41% of Banque de Luxembourg Investments (BLI)'s portfolio in Q1 2026, its #65 holding.
  • Banque de Luxembourg Investments (BLI) first reported a position in West Pharmaceutical in Q4 2024 and has held it in 6 quarters since.
  • Banque de Luxembourg Investments (BLI)'s West Pharmaceutical position peaked at $16.8M in Q4 2024.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q1 2026, filed 15 May 2026.